PATENT CLAIM ANALYSIS

Application Number: 15874758
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.

Claim (Index 54):
An isolated nucleic acid encoding an anti-hemagglutinin antibody comprising three heavy chain hypervariable regions (HVR-H1, HVR-H2, and HVR-H3) and three light chain hypervariable regions (HVR-L1, HVR-L2, and HVR-L3), wherein:\n (a) HVR-H1 comprises the amino acid sequence of SEQ ID NO:178; (b) HVR-H2 comprises the amino acid sequence of SEQ ID NO:179; (c) HVR-H3 comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:180 and 181; (d) HVR-L1 comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:182, 183, 184, 185, and 186; (e) HVR-L2 comprises the amino acid sequence of SEQ ID NO:187; and (f) HVR-L3 comprises an amino acid sequence selected from the group consisting of SEQ ID NOs:188, 189, and 190.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.1875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14077414', '14275174', '14725508', '15042436', '14669317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8407529923635648
- 35 USC 102 Novelty (BERT): 0.7038400034498523
- Combined Prediction Score: 0.8270616934721936
- Mean Citation Score: 755.57028
- Max Citation Score: 812.2035
- Similarity Product: 719.0487291694881

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test